Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery

► Candidate TB vaccine MVA85A is well tolerated intramuscularly or intradermally. ► Both routes are highly immunogenic. ► MVA85A-induced CD4+ T cell cytokine production was similar between the two routes.